Grindlays Pharmaceuticals Pvt Ltd - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Grindlays Pharmaceuticals Pvt Ltd

Grindlays Pharmaceuticals Pvt Ltd, a active private limited company, was established on 04 September 1985 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U99999MH1985PTC037368. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 12 professional, Its leadership includes Arti Ramkrishna Kolwankar (Director), Ramkrishna Harishet Kolwankar (Managing Director), Santosh Ramkrishna Kolwankar (Director). Past directors included Santosh Ramkrishna Kolwankar. It holds ₹5.86 Cr open charges and ₹9.60 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai, Maharashtra, 400071.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1985PTC037368

  • Registration Number

    037368

  • Incorporation Date

    04 September 1985

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.86 Cr
  • Satisfied Charges ₹ 9.60 Cr
  • Revenue Growth **** 104.13%
  • Profit Growth **** 165.52%
  • Ebitda **** 69.53%
  • Net Worth 49.54%
  • Total Assets **** 39.34%
Company report

Grindlays Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Grindlays Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Grindlays Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Arti Ramkrishna Kolwankar Director 01 Apr 1997 Current
Ramkrishna Harishet Kolwankar Managing Director 15 Oct 1985 Current
Santosh Ramkrishna Kolwankar Director 16 Nov 2009 Current
Dhanashri Girish Gudi Director 31 Mar 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Grindlays Pharmaceuticals.

Grindlays Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 104.13% increase. The company also saw a substantial improvement in profitability, with a 165.52% increase in profit. The company's net worth Soared by an impressive increase of 49.54%.

Grindlays Pharmaceuticals revenue growth over time
Grindlays Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 104.13%
*******
*******
*******
*******
Revenue from Operations
*******
 106.51%
*******
*******
*******
*******
Total Assets
*******
 39.34%
*******
*******
*******
*******
Profit or Loss
*******
 165.52%
*******
*******
*******
*******
Net Worth
*******
 49.54%
*******
*******
*******
*******
EBITDA
*******
 69.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Grindlays Pharmaceuticals?

In 2022, Grindlays Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹58,550,000.00

Satisfied Charges

₹95,960,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 5.86 Cr
Latest Charge Details
Date Lender Amount Status
27 Sep 2008 Bank Of India ₹5.86 Cr Open
31 Jul 2013 Deutsche Bank Ag ₹3.55 Cr Satisfied
18 Mar 2009 Bank Of India ₹1.20 M Satisfied
27 Sep 2008 Bank Of India ₹3.50 Cr Satisfied
02 Aug 2004 Bank Of India ₹1.90 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Grindlays Pharmaceuticals?

Grindlays Pharmaceuticals has a workforce of 12 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Grindlays Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grindlays Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Grindlays Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Grindlays Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Grindlays Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Charges

    The activity A charge registered on 18 Mar 2009 via Charge ID 10151901 with Bank Of India was fully satisfied on 14 Dec 2020. was completed.

  • Charges

    The activity A charge registered on 27 Sep 2008 via Charge ID 10129799 with Bank Of India was fully satisfied on 14 Dec 2020. was completed.

  • Charges

    A charge registered on 02 Aug 2004 via Charge ID 90214119 with Bank Of India was fully satisfied on 14 Dec 2020. was recorded as a recent event.

  • Charges

    A charge registered on 31 Jul 2013 via Charge ID 10448577 with Deutsche Bank Ag was fully satisfied on 19 Nov 2020. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Grindlays Pharmaceuticals Pvt Ltd?

The CIN of Grindlays Pharmaceuticals Pvt Ltd is U99999MH1985PTC037368.

Where is Grindlays Pharmaceuticals Pvt Ltd headquartered?

Grindlays Pharmaceuticals Pvt Ltd is headquartered at Office Number 406, 407, 408, 4Th Floor Swastik Chambers, Cst Road, Chembur, Mumbai, Maharashtra, 400071.

When was Grindlays Pharmaceuticals Pvt Ltd incorporated?

Grindlays Pharmaceuticals Pvt Ltd was incorporated on 04 September 1985.

Who are the current directors of Grindlays Pharmaceuticals Pvt Ltd?

The current directors of Grindlays Pharmaceuticals Pvt Ltd are

What is the primary industry of Grindlays Pharmaceuticals Pvt Ltd?

The primary industry of Grindlays Pharmaceuticals Pvt Ltd is Manufacturing.

Is Grindlays Pharmaceuticals Pvt Ltd a listed company?

Grindlays Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of Grindlays Pharmaceuticals Pvt Ltd?

The authorized capital of Grindlays Pharmaceuticals Pvt Ltd is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Grindlays Pharmaceuticals Pvt Ltd?

The compliance status of Grindlays Pharmaceuticals Pvt Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available